Transaction by Person Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
The interest of Simon Lowth, a Director of the Company, in AstraZeneca PLC ordinary shares, has changed as detailed below.
On 7 May 2013, Mr Lowth received shares from the vesting of a previously announced award made in May 2010 under the AstraZeneca Performance Share Plan whereby, following the application of performance measures specified at the time of grant, he has now become beneficially entitled to 47% of the shares originally awarded. In accordance with the plan rules, any unvested part of the award has immediately and irrevocably lapsed. Sufficient shares were withheld to cover certain tax obligations arising on the vesting.
Name |
Shares awarded |
Shares vested |
Shares withheld |
Net shares received |
Market price on vesting |
Simon Lowth |
52,009 |
24,444 |
11,489 |
12,955 |
3339.5p |
As a result of this transaction, Mr Lowth has an interest in 260,877 ordinary shares, which represents approximately 0.02% of the Company's issued ordinary capital.
A C N Kemp
Company Secretary
8 May 2013